MYC and hepatocellular carcinoma: CPG‐based prognostic biomarker preselection resulted in the detection of enriched FA/GO terms, where the enrichment for TER genes substantially predominated over the enrichment for cell cycle/cell division genes (Figs 1F and S4; see also the Supporting information: MYC as a key regulator of ribosomal pathway in HCC PT and AT).